Did you mean
conference

Search results - 5 results

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.

CI: 95-96) against Delta to 87% (95%  CI: 86-89) against Omicron. VE h against Omicron waned to 73% (95%  CI: 71-75) 100-150 days after booster vaccination. While recent prior infections conferred higher ...

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.

adjusted for personal characteristics (age, sex, household), background exposure, calendar week, VOC and time since immunity conferring-event. FINDINGS: VET-estimates were higher for mRNA-vaccines, over 90%, ...

Development of a multiplex immunoassay for simultaneous detection of antigens in DTaP vaccines

Publication Type: Scientific poster, presentation or proceeding Authors: Maxime Vermeulen; Isabelle Feck; Alexandre Dobly Source: Global Conference on Vaccine Research and Developpment, PAGES, ...

Panel discussion on CMC in 'Risk- based strategies to support current health emergency

Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: World Vaccine Conference (EU), Terrapinn, Web based (2020) Health Topics:  Effectiveness and safety of ...

Involvement of the Belgian OMCL in the COVID-19 crisis

Publication Type: Scientific poster, presentation or proceeding Authors: Eric Deconinck Source: OMCL annual meeting General Session, EDQM, Issue EDQM, tele conference (2020) Health Topics:  ...

QR code

QR code for this page URL